Alerts will be sent to your verified email
Verify Email
SYNGENE
|
Syngene Internation.
|
Piramal Pharma
|
Laurus Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
12.33 % | 3.82 % | 18.77 % |
|
5yr average Equity Multiplier
|
1.57 | 1.94 | 2.06 |
|
5yr Average Asset Turnover Ratio
|
0.52 | 0.55 | 0.71 |
|
5yr Avg Net Profit Margin
|
15.3 % | 3.51 % | 11.95 % |
|
Price to Book
|
6.08 | 3.22 | 10.55 |
|
P/E
|
56.68 | 267.15 | 92.75 |
|
5yr Avg Cash Conversion Cycle
|
-6453.7 Days | -19.3 Days | 91.73 Days |
|
Inventory Days
|
20.52 Days | 70.13 Days | 114.71 Days |
|
Days Receivable
|
48.33 Days | 77.05 Days | 120.6 Days |
|
Days Payable
|
-264.76 Days | 159.9 Days | 145.16 Days |
|
5yr Average Interest Coverage Ratio
|
16.15 | 2.86 | 8.98 |
|
5yr Avg ROCE
|
13.11 % | 6.75 % | 22.73 % |
|
5yr Avg Operating Profit Margin
|
29.04 % | 15.15 % | 24.36 % |
|
5 yr average Debt to Equity
|
0.15 | 0.62 | 0.56 |
|
5yr CAGR Net Profit
|
4.15 % | -35.79 % | -18.29 % |
|
5yr Average Return on Assets
|
7.88 % | 2.03 % | 8.99 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.68 % | 34.86 % | 27.59 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 2.69 % |
|
Change in Promoter Holding (3 Yrs)
|
-17.61 % | 0.07 % | 0.32 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
17.91 % | 11.78 % | 3.01 % |
|
Syngene Internation.
|
Piramal Pharma
|
Laurus Labs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|